Eleni Moschouri, Julien Vionnet, Emiliano Giostra, Cécile Daccord, Romain Lazor, Amedeo Sciarra, Igor Letovanec, Christine Sempoux, Michel Gonzalez, Sheila Unger, Heidi Fodstad, Monika Haubitz, Gabriela Maria Baerlocher, Sophie Voruz, Olaia Naveiras, Emmanuel Jacquemin, Darius Moradpour, Montserrat Fraga – 20 February 2020
Harendran Elangovan, Sashen Rajagopaul, Suzanne M. Williams, Benjamin McKillen, Laurence Britton, Steven M. McPhail, Leigh U. Horsfall, Patricia C. Valery, Kelly L. Hayward, Elizabeth E. Powell – 20 February 2020 – Primary care physicians (PCPs) have the primary role in the diagnosis and management of nonalcoholic fatty liver disease (NAFLD), and in selecting patients for referral to a hepatologist for further evaluation.
Today’s high-profile hacks of major organizations and institutions have increased awareness of the issues of digital security, yet most people are compromising their privacy & security on a regular basis, which can put themselves – and their institution – at risk. Attendees at this webinar will better understand the digital risks and learn to separate truth from hype about how secure their presence is.
Henrik Junger, Birgit Knoppke, Kilian Weigand, Katja Evert, Frank W. Brennfleck, Michael Melter, Hans J. Schlitt, Stefan M. Brunner – 17 February 2020
Neil Kaplowitz, Tin Aung Than, Sanda Win – 17 February 2020
Henrik Junger, Birgit Knoppke, Kilian Weigand, Katja Evert, Frank W. Brennfleck, Michael Melter, Hans J. Schlitt, Stefan M. Brunner – 17 February 2020
Alessandro Vitale, Franco Trevisani, Fabio Farinati, Umberto Cillo – 16 February 2020 – Treatment allocation is extremely complex in patients with hepatocellular carcinoma (HCC) because this neoplasm arises, in most cases, in patients with cirrhosis and additional comorbidities. The “stage hierarchy” approach, which involves linking each stage (or substage) of the disease to a specific treatment, has become the main proposed treatment strategy for the clinical management of HCC, particularly in the West.
Akanksha Sharma, Alok K. Verma, Matthew Kofron, Ramesh Kudira, Alexander Miethke, Tong Wu, Jiang Wang, Chandrashekhar R. Gandhi – 16 February 2020
Nikhil Kapila, Asad Ur Rahman, Xaralambos B. Zervos – 16 February 2020
Alessandro Vitale, Franco Trevisani, Fabio Farinati, Umberto Cillo – 16 February 2020 – Treatment allocation is extremely complex in patients with hepatocellular carcinoma (HCC) because this neoplasm arises, in most cases, in patients with cirrhosis and additional comorbidities. The “stage hierarchy” approach, which involves linking each stage (or substage) of the disease to a specific treatment, has become the main proposed treatment strategy for the clinical management of HCC, particularly in the West.